These mice survived for a total of 25 days and naturally died, which we defined as the survival endpoint as illustrated in Fig
Youll likely notice more significant changes in body composition, as fat loss becomes the primary driver of weight reduction
Regular follow-ups may be required, especially during the first few months of the switch
Unknown Risks with Prolonged Use: As with any treatment, the long-term effects beyond a decade of continuous use are not fully studied, emphasizing the need for periodic medical evaluations
The clinical data on how common this is From the published SURPASS and SURMOUNT trials: Mounjaro has a slightly higher injection site reaction rate than other GLP-1 medications, likely because of the dual agonist mechanism (more immune recognition events) and the larger injection volume (0.5 mL vs 0.25 to 0.375 mL for semaglutide)
Semaglutide: How it works and what it costs Semaglutides (Ozempic, Wegovy, Rybelsus) are GLP-1 agonists